Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Banys-Paluchowskil, Malgorzata; Krawczyk, Natalia; Friebe, Verena et al.
Immunotherapy for breast cancerGYNAKOLOGE. Bd. 52. H. 5. 2019 S. 343-353
Mayer, Frank; Pleimes, Dirk; Schmidt, Marcus et al.
Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Skala, C; Steetskamp, J; Albrich, S
Klinische Relevanz des Ultraschalls in der UrogynäkologieFrauenheilkunde up2date. Bd. 13. H. 5. 2019 S. 459-469
Cadenas, Cristina; Vosbeck, Sonja; Edlund, Karolina et al.
LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancerINTERNATIONAL JOURNAL OF CANCER. Bd. 145. H. 4. 2019 S. 901-915
Battista, Marco Johannes; Schnatz, Carola; Almstedt, Katrin et al.
Low-dose metronomic chemotherapy (LDMC) as an efficient treatment option in metastatic breast cancer: Results of an exploratory case-control study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Polterauer, Stephan; Schwameis, Richard; Grimm, Christoph et al.
Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 studyGYNECOLOGIC ONCOLOGY. Bd. 153. H. 2. 2019 S. 286-291
Weikel, W
Lymphonodektomie beim Vulvakarzinom: Wann und wie vorgehen?Frauenheilkunde up2date. Bd. 13. H. 4. 2019 S. 355-365
Heesen, Ludwig; Frenzel, Katrin; Bolte, Stefanie et al.
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)CANCER RESEARCH. Bd. 79. H. 13. 2019
Hasenburg, A.
Neoadjuvant Chemotherapy for Ovarian Cancer?GYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638
Hasenburg, A.
Ovarian Cancer Recurrence: Antiangiogenesis delays ProgressionGYNAKOLOGE. Bd. 52. H. 9. 2019 S. 638-638